Lysophosphatidylcholine is involved in the antigenicity of oxidized LDL

被引:63
作者
Wu, RH
Huang, YH
Elinder, LS
Frostegård, J [1 ]
机构
[1] Karolinska Hosp, Dept Med, Unit Rheumatol & CMM, S-17177 Stockholm, Sweden
[2] Karolinska Inst, King Gustaf V Res Inst, Dept Med, Stockholm, Sweden
关键词
lysophosphatidylcholine; antibodies; oxidized LDL; autoimmune diseases; atherosclerosis;
D O I
10.1161/01.ATV.18.4.626
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Lysophosphatidylcholine (LPC) is formed by hydrolysis of PC in low density lipoprotein (LDL) and cell membranes by phospholipase A(2) or by oxidation. Oxidized (ox) LDL activates endothelial cells, an effect mimicked by LPC. oxLDL also has the capacity to activate T and B cells, and antibody titers to oxLDL are related to the degree of atherosclerosis. The antigen in oxLDL responsible for its immune-stimulatory capacity is not well characterized, and we hypothesized that LPC was involved. We demonstrate herein the presence of antibodies against LPC, both of the IgG and IgM isotype, in 210 healthy individuals. This antibody reactivity was not specifically related to oxidation of the fatty acid moiety in LPC, since LPC containing only palmitic acid showed antibody titers equivalent to those of LPC containing unsaturated fatty acids. Antibody titers to PC were low compared with LPC, and hydrolysis of PC at the sn-2 position is thus essential for immune reactivity, There was a close correlation between anti-oxLDL and anti-LPC antibodies. Furthermore, LPC competitively inhibited anti-oxLDL reactivity which indicates that LPC may explain a significant part of the immune-stimulatory properties of oxLDL. LPC, being a lipid, is not likely to be an antigen itself. Instead, LPC could form immunogenic complexes with peptides, which may induce and potentiate immune reactions in the vessel wall. This study adds to the evidence that LPC is an important component of oxLDL and emphasizes the potential role of phospholipase A(2) in atherosclerosis.
引用
收藏
页码:626 / 630
页数:5
相关论文
共 34 条
[1]   PATIENTS WITH EARLY-ONSET PERIPHERAL VASCULAR-DISEASE HAVE INCREASED LEVELS OF AUTOANTIBODIES AGAINST OXIDIZED LDL [J].
BERGMARK, C ;
WU, R ;
DEFAIRE, U ;
LEFVERT, AK ;
SWEDENBORG, J .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (04) :441-445
[2]   INDUCTION OF T-CELL ACTIVATION BY OXIDIZED LOW-DENSITY-LIPOPROTEIN [J].
FROSTEGARD, J ;
WU, RH ;
GISCOMBE, R ;
HOLM, G ;
LEFVERT, AK ;
NILSSON, J .
ARTERIOSCLEROSIS AND THROMBOSIS, 1992, 12 (04) :461-467
[3]  
GLADMAN D D, 1990, Current Opinion in Rheumatology, V2, P694
[4]   A role for secretory phospholipase A(2) and C-reactive protein in the removal of injured cells [J].
Hack, CE ;
Wolbink, GJ ;
Schalkwijk, C ;
Speijer, H ;
Hermens, WT ;
vandenBosch, H .
IMMUNOLOGY TODAY, 1997, 18 (03) :111-115
[5]  
HAMSTEN A, 1986, LANCET, V1, P113
[6]  
HANSSON GK, 1989, AM J PATHOL, V135, P169
[7]  
HARRIS EN, 1994, SPRINGER SEMIN IMMUN, V16, P223
[8]  
HARRIS EN, 1986, CLIN EXP IMMUNOL, V68, P215
[9]   DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM [J].
HAVEL, RJ ;
EDER, HA ;
BRAGDON, JH .
JOURNAL OF CLINICAL INVESTIGATION, 1955, 34 (09) :1345-1353
[10]   Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids - Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein [J].
Horkko, S ;
Miller, E ;
Dudl, E ;
Reaven, P ;
Curtiss, LK ;
Zvaifler, NJ ;
Terkeltaub, R ;
Pierangeli, SS ;
Branch, DW ;
Palinski, W ;
Witztum, JL .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (03) :815-825